FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.4.11  |  FHIR Version n/a  User: [n/a]

Resource ValueSet/FHIR Server from package us.nlm.vsac#0.21.0 (78 ms)

Package us.nlm.vsac
Type ValueSet
Id Id
FHIR Version R4
Source http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.1444.5.206/expansion
Url http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.206
Version 20200902
Status active
Date 2020-09-02T01:00:26-04:00
Name TrastuzumabAndBiosimilars
Title Trastuzumab and Biosimilars
Experimental False
Realm us
Authority hl7
Purpose (Clinical Focus: This value set contains concepts that represent the medication Trastuzumab and Trastuzumab biosimilars.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; injectable Trastuzumab and Trastuzumab biosimilars.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable.)

Resources that use this resource

No resources found

Resources that this resource uses

CodeSystem
http://www.nlm.nih.gov/research/umls/rxnorm RxNorm
http://www.nlm.nih.gov/research/umls/rxnorm RxNorm
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.101 Trastuzumab and Biosimilars

Source

{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.1444.5.206",
  "meta" : {
    "versionId" : "6",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail" : {
        "name" : "American Society of Clinical Oncology Author"
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-11-25"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2020-09-02"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.206",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113883.3.1444.5.206"
    }
  ],
  "version" : "20200902",
  "name" : "TrastuzumabAndBiosimilars",
  "title" : "Trastuzumab and Biosimilars",
  "status" : "active",
  "experimental" : false,
  "date" : "2020-09-02T01:00:26-04:00",
  "publisher" : "American Society of Clinical Oncology Steward",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: This value set contains concepts that represent the medication Trastuzumab and Trastuzumab biosimilars.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; injectable Trastuzumab and Trastuzumab biosimilars.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable.)",
  "compose" : {
    "include" : [
      {
        "valueSet" : [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.101"
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:bbbd2363-bc27-4e80-9128-8195e99c17d8",
    "timestamp" : "2024-12-10T10:12:38-05:00",
    "total" : 18,
    "contains" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1658084",
        "display" : "ado-trastuzumab emtansine 100 MG Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1658089",
        "display" : "ado-trastuzumab emtansine 160 MG Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1922509",
        "display" : "trastuzumab 150 MG Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1922516",
        "display" : "trastuzumab 21 MG/ML Injectable Solution"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "2107053",
        "display" : "trastuzumab-pkrb 21 MG/ML Injectable Solution"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "2119714",
        "display" : "5 ML hyaluronidase-oysk 2000 UNT/ML / trastuzumab-oysk 120 MG/ML Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "2169359",
        "display" : "trastuzumab-pkrb 150 MG Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "2174804",
        "display" : "trastuzumab-anns 21 MG/ML Injectable Solution"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "2179753",
        "display" : "trastuzumab-dkst 150 MG Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "2179760",
        "display" : "trastuzumab-dkst 21 MG/ML Injectable Solution"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "2257297",
        "display" : "trastuzumab-anns 150 MG Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "2267576",
        "display" : "fam-trastuzumab deruxtecan-nxki 100 MG Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "2280732",
        "display" : "trastuzumab-qyyp 21 MG/ML Injectable Solution"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "2289227",
        "display" : "trastuzumab-dttb 150 MG Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "2289234",
        "display" : "trastuzumab-dttb 21 MG/ML Injectable Solution"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "2382604",
        "display" : "15 ML hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 80 MG/ML / trastuzumab-zzxf 40 MG/ML Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "2383305",
        "display" : "10 ML hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 60 MG/ML / trastuzumab-zzxf 60 MG/ML Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "2472791",
        "display" : "trastuzumab-qyyp 150 MG Injection"
      }
    ]
  },
  "text" : {
  }
}

XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.